RADUS: Assessment of the Ionizing Radiation Received During Percutaneous or Conventional Surgery of Hallux Valgus

Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05174702
Collaborator
(none)
70
4

Study Details

Study Description

Brief Summary

To assess the average whole body radiation dose received by the surgeon, the operating team and the patient during hallux valgus surgery, depending on whether the surgery is percutaneous or conventional.

Condition or Disease Intervention/Treatment Phase
  • Radiation: Irradiation collected at the end of the operation on the active dosimeter

Detailed Description

Prospective, open, comparative, non-randomized, non-interventional, single-center study, focusing on two surgical strategies. Patients will be managed in accordance with current practice, the choice of surgical strategy being left to the discretion of the investigators.

Patients will be informed of the study during a preoperative visit. The data concerning them will be collected on the day of the surgery. No follow-up over time is necessary.

Passive "ring" and "cornea" dosimeters will be worn by healthcare professionals during procedures for patients included in the study. Their data will be collected each month and at the end of the study, and reported secondarily to the number of operations. Several surgeons, dressers and operating assistants will participate in the operations, their data will be aggregated taking into account their function and not individuals.

Study Design

Study Type:
Observational
Anticipated Enrollment :
70 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Assessment of the Ionizing Radiation Received by the Patient and the Nursing Staff During Percutaneous or Conventional Surgery of Hallux Valgus
Anticipated Study Start Date :
May 1, 2022
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Sep 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Percutaneous surgery

Patient will have a percutaneous hallus valgus surgery

Radiation: Irradiation collected at the end of the operation on the active dosimeter
Mesure of the irradiation collected at the end of the operation on the active dosimeter for the surgeon, the patient and the operating team

conventional surgery

Patient will have a conventional hallus valgus surgery

Radiation: Irradiation collected at the end of the operation on the active dosimeter
Mesure of the irradiation collected at the end of the operation on the active dosimeter for the surgeon, the patient and the operating team

Outcome Measures

Primary Outcome Measures

  1. Irradiation collected at the end of the operation on the surgeon's active dosimeter [during the time of the surgery]

    Measure of irradiation in mSv by a dosimeter

  2. Irradiation collected at the end of the operation on the surgeon's active dosimeter [during the time of the surgery]

    Measure of irradiation in mGy.cm² by a dosimeter

Secondary Outcome Measures

  1. Irradiation collected at the end of the operation on the patient's and operating team's [during the time of the surgery]

    Measure of irradiation in mSv by a dosimeter

  2. Irradiation collected at the end of the operation on the patient's and operating team's [during the time of the surgery]

    Measure of irradiation in mGy.cm² by a dosimeter

  3. Irradiation collected on the passive "ring" and "cornea" dosimeters of each health professional [3 months]

    Measure of irradiation in mSv by a dosimeter

  4. Irradiation collected on the passive "ring" and "cornea" dosimeters of each health professional [3 months]

    Measure of irradiation in mGy.cm² by a dosimeter

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient undergoing percutaneous or conventional hallux valgus surgery;

  • Patient capable of understanding the information related to the study, of reading the information leaflet and having expressed his non-opposition to participating in the study.

Exclusion Criteria:
  • Pregnant or breastfeeding woman;

  • Patient under guardianship or curatorship, or under a regime of deprivation of liberty.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • GCS Ramsay Santé pour l'Enseignement et la Recherche

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
GCS Ramsay Santé pour l'Enseignement et la Recherche
ClinicalTrials.gov Identifier:
NCT05174702
Other Study ID Numbers:
  • 2021-A02408-33
First Posted:
Jan 3, 2022
Last Update Posted:
Apr 27, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 27, 2022